Who
Leslie J. Williams
Director
Company insider
Files Form 4 as: Director, Ocular Therapeutix; Director, Windtree Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 1
- Sells
- 0
- Bought
- $20K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 20 Mar 2019
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 24 Jul 2024filed 26 Jul 2024 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 24 Jul 2024filed 26 Jul 2024 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 23 Aug 2023filed 25 Aug 2023 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,050 at $0.00 | filing |
| 23 Aug 2023filed 25 Aug 2023 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,033 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,800 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —8,933 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 18 Jun 2021filed 22 Jun 2021 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 3 Feb 2021filed 5 Feb 2021 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 Jun 2020filed 26 Jun 2020 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 14 Jun 2019filed 17 Jun 2019 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Bought | $20K4,500 at $4.40 | filing |
News
Ocular Therapeutix (NASDAQ:OCUL) Stock: Insider Todd Anderman Sells 11,984 SharesOCUL · themarketsdaily.com · 15 Oct 2026Ocular Therapeutix (NASDAQ:OCUL) Upgraded to Strong-Buy at UBS GroupOCUL · dailypolitical.com · 14 Oct 2026Contrasting Ocular Therapeutix (NASDAQ:OCUL) and Bausch Health Cos (NYSE:BHC)OCUL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Leslie J. Williams; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.